Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

491 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of cannabinoids in neurodegenerative diseases.
Glass M. Glass M. Prog Neuropsychopharmacol Biol Psychiatry. 2001 May;25(4):743-65. doi: 10.1016/s0278-5846(01)00162-2. Prog Neuropsychopharmacol Biol Psychiatry. 2001. PMID: 11383976 Review.
Cannabinoid Receptors: A brief history and what not.
Graham ES, Ashton JC, Glass M. Graham ES, et al. Among authors: glass m. Front Biosci (Landmark Ed). 2009 Jan 1;14:944-57. doi: 10.2741/3288. Front Biosci (Landmark Ed). 2009. PMID: 19273110 Review.
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ, Bradshaw HB, Howard ML, Nicholson LF, Faull RL, Hannan AJ, Glass M. Dowie MJ, et al. Among authors: glass m. Neuroscience. 2009 Sep 29;163(1):456-65. doi: 10.1016/j.neuroscience.2009.06.014. Epub 2009 Jun 10. Neuroscience. 2009. PMID: 19524019
Loss of cannabinoid CB1 receptor ligand binding in key brain regions is detected early in HD in human postmortem tissue [Glass M, Dragunow M, Faull RL (2000) The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamin …
Loss of cannabinoid CB1 receptor ligand binding in key brain regions is detected early in HD in human postmortem tissue [Glass M
491 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page